This work is a literature overview on angiotensin‐converting enzyme (ACE) inhibitory/
antihypertensive peptides in food protein sources. The following aspects related to peptides …

Bioactive food peptides are encrypted within the sequence of food proteins but can be
released during food processing (by enzymatic hydrolysis or fermentation) or during …

Hypertension is one of the main causes of cardiovascular diseases. Synthetic drugs
inhibiting ACE activity present high effectiveness in the treatment of hypertension but cause …

Angiotensin‐I‐converting enzyme (ACE) inhibitory peptides are able to inhibit the activity of
ACE, which is the key enzymatic factor mediating systemic hypertension. ACE‐inhibitory …

In recent decades, the most successful strategy for controlling blood pressure has been
inhibition of the angiotensin-converting enzyme (ACE). ACE inhibitors of chemical synthesis …

Bioactive peptides from food proteins exert beneficial effects on human health, such as
angiotensin-converting enzyme (ACE) inhibition and antihypertensive activity. Several …

Bioactive peptides within the original food-derived proteins are inactive but can be activated
by releasing them during food processing (by enzymatic hydrolysis or fermentation) or …

Hypertension is a non-communicable disease characterized by elevated blood pressure,
and a prominent metabolic syndrome of modern age. Food-borne bioactive peptides have …

Hypertension is an important factor in cardiovascular diseases. Angiotensin-I-converting
enzyme (ACE) inhibitors like synthetic drugs are widely used to control hypertension. ACE …

Background Despite their efficiency, antihypertensive pharmacological synthetic drugs, such
as the angiotensin-converting enzyme (ACE) inhibitors are often associated with serious …